Ovid Therapeutics Inc. (OVID) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$15.68M*; Operating income -$15.70M; Depreciation and amortization $16.00K*.
- 2026-03-31: Basis Reported; EBITDA -$17.81M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$12.28M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$12.51M*; Operating income -$12.52M; Depreciation and amortization $16.00K*.
Complete source-backed ebitda history.
- Available history
- 2015-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$15.68M* | -$15.70M | $16.00K* | $733.00K | -2139.43%* | (m) | -$17.59M* | (m) | $9.96M | (m) | $0.00 |
|---|
| 2026-03-31 | Reported | -$17.81M | (m) | (m) | (m) | (m) | (m) | -$13.90M | (m) | $11.18M | (m) | $0.00 |
|---|
| 2025-12-31 | Reported | -$12.28M | (m) | (m) | (m) | -1709.75% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$12.51M* | -$12.52M | $16.00K* | $132.00K | -9475.00%* | $0.00* | -$12.87M* | (m) | $5.87M | (m) | $0.00 |
|---|
| 2025-06-30 | Reported | -$4.97M* | -$5.07M | $99.00K* | $6.27M | -79.30%* | $0.00* | -$4.77M* | (m) | $6.46M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | -$12.41M | (m) | (m) | (m) | -9545.38% | $0.00 | -$10.28M | (m) | $6.66M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$10.56M | (m) | (m) | (m) | -13897.37% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$13.06M* | -$13.23M | $169.00K* | $173.00K | -7547.40%* | -$4.00K* | -$15.01M* | (m) | $7.86M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | -$20.37M* | -$20.52M | $148.00K* | $169.00K | -12052.66%* | $34.00K* | -$14.26M* | (m) | $12.58M | (m) | $0.00 |
|---|
| 2024-03-31 | Reported | -$17.28M | (m) | (m) | (m) | -11676.35% | $19.00K | -$16.69M | (m) | $10.40M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$18.05M | (m) | (m) | (m) | -12709.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$11.88M* | -$12.03M | $146.00K* | $109.00K | -10901.83%* | $6.00K* | -$10.05M* | (m) | $5.33M | (m) | $0.00 |
|---|
| 2023-06-30 | Reported | -$14.04M* | -$14.17M | $137.00K* | $75.00K | -18713.33%* | $7.00K* | -$11.71M* | (m) | $6.00M | (m) | $0.00 |
|---|
| 2023-03-31 | Reported | -$14.75M | (m) | (m) | (m) | -22343.94% | $14.00K | -$12.11M | (m) | $6.62M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$11.99M | (m) | (m) | (m) | -25903.05% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$12.65M* | -$12.80M | $155.42K* | $11.10K | -113929.35%* | $18.60K* | -$12.68M* | (m) | $5.18M | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | -$14.21M* | -$14.30M | $98.30K* | $0.00 | (m) | $1.04M* | -$13.29M* | (m) | $6.05M | (m) | $0.00 |
|---|
| 2022-03-31 | Reported | -$16.19M | (m) | (m) | (m) | -1120.36% | $45.94K | -$20.09M | (m) | $7.83M | (m) | $50.00K |
|---|
| 2021-12-31 | Reported | -$26.3M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$11.63M* | -$11.68M | $52.18K* | (m) | (m) | $22.05K* | -$10.87M* | (m) | $4.92M | (m) | -$294.83K |
|---|
| 2021-06-30 | Reported | -$14.26M* | -$14.31M | $53.22K* | (m) | (m) | -$11.51K* | -$19.42M* | (m) | $7.68M | (m) | $1.47M |
|---|
| 2021-03-31 | Reported | $176.63M | (m) | (m) | (m) | 84.76% | $11.51K | $160.90M | (m) | $16.25M | (m) | $500.28K |
|---|
| 2020-12-31 | Reported | -$21.51M | (m) | (m) | (m) | -377.13% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$16.32M* | -$16.40M | $78.92K* | (m) | (m) | $18.30K* | -$1.47M* | (m) | $15.88M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$23.06M* | -$23.14M | $78.01K* | (m) | (m) | $52.91K* | -$17.19M* | (m) | $16.03M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$20.23M | (m) | (m) | (m) | (m) | $14.14K | -$18.41M | (m) | $14.63M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$17.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$16.71M* | -$16.77M | $55.40K* | (m) | (m) | $18.21K* | -$9.49M* | (m) | $11.60M | (m) | (m) |
|---|
| 2019-06-30 | Reported | -$13.25M* | -$13.32M | $69.26K* | (m) | (m) | $3.38K* | -$11.84M* | (m) | $9.12M | (m) | (m) |
|---|
| 2019-03-31 | Reported | -$13.98M | (m) | (m) | (m) | (m) | $4.32K | -$12.87M | (m) | $9.34M | (m) | (m) |
|---|
| 2018-12-31 | Reported | -$13.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | -$13.14M* | -$13.18M | $34.75K* | (m) | (m) | $10.63K* | -$10.05M* | (m) | $8.54M | (m) | (m) |
|---|
| 2018-06-30 | Reported | -$13.18M* | -$13.21M | $25.32K* | (m) | (m) | $21.28K* | -$11.62M* | (m) | $8.12M | (m) | (m) |
|---|
| 2018-03-31 | Reported | -$13.4M | (m) | (m) | (m) | (m) | $7.58K | -$12.93M | (m) | $8.47M | (m) | (m) |
|---|
| 2017-12-31 | Reported | -$11.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-09-30 | Reported | -$9.39M* | -$9.41M | $21.04K* | (m) | (m) | $9.11K* | -$9.32M* | (m) | $5.90M | (m) | (m) |
|---|
| 2017-06-30 | Reported | -$10.27M* | -$10.29M | $19.09K* | (m) | (m) | $9.87K* | (m) | (m) | $6.07M | (m) | (m) |
|---|
| 2017-03-31 | Reported | -$34.24M | (m) | (m) | (m) | (m) | $12.13K | (m) | (m) | $31.28M | $2.98M | $0.00 |
|---|
| 2016-12-31 | Reported | -$7.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2016-09-30 | Reported | -$5.81M* | -$5.81M | $9.19K* | (m) | (m) | $4.99K* | (m) | (m) | $2.70M | (m) | (m) |
|---|
| 2016-06-30 | Reported | -$5.41M* | -$5.42M | $8.67K* | (m) | (m) | $7.30K* | (m) | (m) | $1.77M | (m) | (m) |
|---|
| 2016-03-31 | Reported | (m) | (m) | $5.90K | (m) | (m) | $14.65K | (m) | (m) | $1.13M | $2.59M | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$42.17M | (m) | (m) | (m) | -581.44% | $0.00 | -$38.33M | (m) | $25.58M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$61.27M | (m) | (m) | (m) | -10825.44% | $71.00K | -$55.96M | (m) | $36.77M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$58.71M | (m) | (m) | (m) | -14977.81% | $40.00K | -$45.78M | (m) | $28.59M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$55.04M | (m) | (m) | (m) | -3662.33% | $1.22M | -$55.23M | (m) | $24.62M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | $124.45M | (m) | (m) | (m) | 59.72% | $184.01K | $118.61M | (m) | $46.94M | (m) | $1.33M |
|---|
| 2020-12-31 | Reported | -$81.12M | (m) | (m) | (m) | -642.96% | $127.24K | -$51.58M | (m) | $63.42M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$61.15M | (m) | (m) | (m) | (m) | $57.16K | -$51.09M | (m) | $42.16M | (m) | $0.00 |
|---|
| 2018-12-31 | Reported | -$52.79M | (m) | (m) | (m) | (m) | $33.87K | -$45.56M | (m) | $33.79M | (m) | $0.00 |
|---|
| 2017-12-31 | Reported | -$64.93M | (m) | (m) | (m) | (m) | $38.91K | -$31.47M | (m) | $49.97M | (m) | $0.00 |
|---|
| 2016-12-31 | Reported | -$22.48M | (m) | (m) | (m) | (m) | $30.36K | (m) | (m) | $9.59M | (m) | (m) |
|---|
| 2015-12-31 | Reported | -$13.18M | (m) | (m) | (m) | (m) | $32.08K | (m) | (m) | $6.61M | (m) | (m) |
|---|